Ms Amanda Hollis > Kirkland & Ellis LLP > Chicago, United States > Lawyer Profile

Kirkland & Ellis LLP
United States


Amanda Hollis is an intellectual property litigator and partner in Kirkland’s Chicago office. Her practice includes all areas of technology, including biotechnology, medical devices, chemistry, computing and electronics, and her clients have included some of the nation’s largest companies, such as Abbott Laboratories, Pfizer, Baxter, Teva, C.R. Bard, IBM, Samsung and Cisco, among others. Amanda has tried and led patent cases in federal courts across the country and in the United States International Trade Commission. She also has served as lead counsel in many inter partes reviews before the United States Patent and Trademark Office’s Patent Trial and Appeal Board. Amanda was named to Benchmark Litigation’s 2016–2019 “Under 40 Hot List,” Law360’s 2018 “Top Attorneys Under 40” for Intellectual Property, and Best Lawyers 2017 “Women of Influence” list. Amanda also was recognized for Patent Litigation in The Legal 500 U.S., 2017–2020 and was recommended in the 2021 edition of the IAM Patent 1000 – The World’s Leading Patent Professionals.


J.D., University of North Carolina School of Law; B.S., the University of Illinois at Urbana-Champaign

Lawyer Rankings

United States > Intellectual property > Patents: litigation (full coverage)

Kirkland & Ellis LLP houses a stellar bench of experienced trial lawyers, including the New York-based Gregory Arovas, Robert Appleby, Joseph Loy, and Todd Friedman; James Hurst, Amanda Hollis, and Bryan Hales in Chicago; Michael De Vries and Ellisen Turner in Los Angeles; Adam Alper in San Francisco; Gregg LoCascio and John O’Quinn in Washington DC; and Jeannie Heffernan in Austin. Operating across the country, the practice is a preferred choice for major industry clients for a wide gamut of patent disputes, litigating cases before district courts, the Federal Circuit, the ITC, the PTAB, and the Supreme Court. The group has particular expertise in the semiconductor, telecommunications, technology, electronics and pharmaceutical industries.